This international, peer-reviewed Open Access journal by Dove Medical Press spans the spectrum of drug design and development through to clinical applications.
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Follow this link for information on the Editors and the Editorial Board Members.
Open Access Publication: All manuscripts submitted to Dove Medical Press are assumed to be submitted under the Open Access publishing model.
In this publishing model, papers are peer-reviewed in the normal way under editorial control. When a paper is accepted for publication the author is issued with an invoice for payment of a publication processing fee. Publication processing fees invoiced to EU countries are subject to 20% VAT. There is no submission charge as such, only the publication processing fee after the paper is accepted for publication. Payment of this charge allows Dove Medical Press to recover its editorial and production costs and create a pool of funds that can be used to provide fee waivers for authors from lesser developed countries.
For more information on the publishing process and publishing fees follow this link.